Close Menu

NEW YORK (GenomeWeb) – The Wyss Institute for Biologically Inspired Engineering at Harvard University has spun out a company called ReadCoor in order to commercialize its fluorescent in situ RNA sequencing technology, FISSEQ. ReadCoor, which also raised $23 million in a recent Series A financing round, has licensed the technology and exclusive marketing rights for FISSEQ from Harvard.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.

Mar
30
Sponsored by
GenomeWeb/ABRF

This webinar features two speakers who will discuss novel computational approaches to optimize sequencing workflows on Oxford Nanopore sequencing platforms.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.